4.6 Article

Recommendations for standardization and phenotype definitions in genetic studies of osteoarthritis: the TREAT-OA consortium

Journal

OSTEOARTHRITIS AND CARTILAGE
Volume 19, Issue 3, Pages 254-264

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.joca.2010.10.027

Keywords

Genetics; Osteoarthritis; Phenotype; Definition; TREATOA

Funding

  1. European Commission [200800]
  2. Netherlands Organisation of Scientific Research NWO Investments [175.010.2005.011, 911-03-012]
  3. Research Institute for Diseases in the Elderly [014-93-015]
  4. Netherlands Genomics Initiative (NGI)/Netherlands Organisation for Scientific Research (NWO), Netherlands Consortium of Healthy Aging and the Erasmus Medical Center
  5. Erasmus University, Rotterdam
  6. deCODE Genetics
  7. Academy of Finland
  8. Finnish Ministry of Education
  9. ORTON Research Institute
  10. National Institutes of Health [AR47785, AG 18393]
  11. Oxford NIHR Musculoskeletal Biomedical Research Unit
  12. Wellcome Trust
  13. Department of Health via the National Institute for Health Research (NIHR) comprehensive Biomedical Research Centre
  14. King's College London
  15. Arthritis Research Campaign
  16. arc
  17. Medical Research Council (UK)
  18. Arthritis Research Council UK [17661, 14581]
  19. Estonian Science Foundation [5308]
  20. Estonian Ministry of Social Affairs [9.6-4/2035, 12.1-5/597]
  21. Swedish Research Council
  22. Lund University
  23. Leiden University Medical Centre
  24. Dutch Arthritis Association
  25. Pfizer Inc., Groton, CT, USA
  26. National Institutes of Health
  27. National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) [R01-AR051124]
  28. National Institute on Aging (NIA) [AG05407, AR35582, AG05394, AR35584, AR35583, R01 AG005407, R01 AG027576-22, 2 R01 AG005394-22A1, R01 AR052000-01 A1, 2K24-AR04884, AR043052, 2 R01 AG027574-22A1]
  29. National Center for Research Resources (NCRR)
  30. NIH Roadmap for Medical Research [R01 AR052000-01 A1, 2K24-AR04884, AR043052, U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]
  31. Grants-in-Aid for Scientific Research [23390361, 19109007] Funding Source: KAKEN
  32. Medical Research Council [U1475000001, MC_UP_A620_1014] Funding Source: researchfish
  33. National Institute for Health Research [NF-SI-0508-10082] Funding Source: researchfish
  34. Versus Arthritis [17489] Funding Source: researchfish

Ask authors/readers for more resources

Objective: To address the need for standardization of osteoarthritis (OA) phenotypes by examining the effect of heterogeneity among symptomatic (SOA) and radiographic osteoarthritis (ROA) phenotypes. Methods: Descriptions of OA phenotypes of the 28 studies involved in the TREAT-OA consortium were collected. We investigated whether different OA definitions result in different association results by creating various hip OA definitions in one large population based cohort (the Rotterdam Study I (RSI)) and testing those for association with gender, age and body mass index using one-way ANOVA. For ROA, we standardized the hip-, knee- and hand ROA definitions and calculated prevalence's of ROA before and after standardization in nine cohort studies. This procedure could only be performed in cohort studies and standardization of SOA definitions was not feasible at this moment. Results: In this consortium, all studies with SOA phenotypes (knee, hip and hand) used a different definition and/or assessment of OA status. For knee-, hip- and hand ROA five, four and seven different definitions were used, respectively. Different hip ROA definitions do lead to different association results. For example, we showed in the RSI that hip OA defined as at least definite joint space narrowing (JSN) and one definite osteophyte was not associated with gender (P=0.22), but defined as at least one definite osteophyte was significantly associated with gender (P=3 x 10(-9)). Therefore, a standardization process was undertaken for ROA definitions. Before standardization a wide range of ROA prevalence's was observed in the nine cohorts studied. After standardization the range in prevalence of knee- and hip ROA was small. Conclusion: Phenotype definitions influence the prevalence of OA and association with clinical variables. ROA phenotypes within the TREAT-OA consortium were standardized to reduce heterogeneity and improve power in future genetics studies. (C) 2010 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available